Novel BQCA- and TBPB-Derived M


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
17 07 2019
Historique:
received: 09 05 2019
revised: 05 06 2019
pubmed: 6 6 2019
medline: 7 7 2020
entrez: 6 6 2019
Statut: ppublish

Résumé

Recently, investigations of the complex mechanisms of allostery have led to a deeper understanding of G protein-coupled receptor (GPCR) activation and signaling processes. In this context, muscarinic acetylcholine receptors (mAChRs) are highly relevant due to their exemplary role in the study of allosteric modulation. In this work, we compare and discuss two sets of putatively dualsteric ligands, which were designed to connect carbachol to different types of allosteric ligands. We chose derivatives of TBPB [1-(1'-(2-tolyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one] as M

Identifiants

pubmed: 31166078
doi: 10.1002/cmdc.201900283
doi:

Substances chimiques

1-(1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo(d)imidazol-2-(3H)-one 0
1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 0
Benzimidazoles 0
Ligands 0
Muscarinic Agonists 0
Piperidines 0
Quinolines 0
Receptor, Muscarinic M1 0
Carbachol 8Y164V895Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1349-1358

Informations de copyright

© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Simon Schramm (S)

Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.

Luca Agnetta (L)

Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.

Marcel Bermudez (M)

Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.

Hubert Gerwe (H)

Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.

Matthias Irmen (M)

Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Strasse 3, 53121, Bonn, Germany.

Janine Holze (J)

Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Strasse 3, 53121, Bonn, Germany.

Timo Littmann (T)

Institute of Pharmacy, University of Regensburg, 93053, Regensburg, Germany.

Gerhard Wolber (G)

Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.

Christian Tränkle (C)

Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Strasse 3, 53121, Bonn, Germany.

Michael Decker (M)

Pharmazeutische und Medizinische Chemie, Institut für Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH